Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | -4.50% | -8.91% | -4.50% |
12/02 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
07/02 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.50% | 27.16M | |
+32.36% | 698B | |
+26.51% | 568B | |
-4.40% | 358B | |
+19.46% | 328B | |
+3.50% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.62% | 165B |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Aker BioMarine Gains Krill Assets from Acasti Pharma in $3.1 Million Settlement Deal